Randomized double-blind multi-dose trial of the oral factor-Xa inhibitor DU-176b versus LMW Heparin (Dalteparin) for prevention of venous thromboembolism after total hip replacement Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Raskob, G
  • Cohen, A
  • Eriksson, B
  • Macdonald, A
  • Puskas, D
  • Shi, M
  • Verho, M
  • Weitz, Jeffrey

publication date

  • September 1, 2008